Hepatitis B Vaccination for Special Needs School Staff in Leicester

Hepatitis B is a blood-borne virus that can be transmitted by needlestick injury, bites that break the skin, scratches, exposure to bodily fluids, and intimate-care contact. The UK Green Book Chapter 18 (updated February 2026) specifically identifies staff working in day-care settings and special schools for those with severe learning disabilities as an occupational group for whom hepatitis B vaccination should be considered, on the basis of a local risk assessment.

The risks in special needs school environments are well-documented. A 2022 study of 1,398 special school staff (Lang et al., Scientific Reports) found that between 66% and 93% of staff had been scratched, bitten or spat at by pupils. Daily physical contact was reported by up to 84% of all employees. Despite the high exposure, only 64% of staff had completed a hepatitis B course, and the largest single predictor of remaining unvaccinated was lack of structured access to vaccine counselling. The barrier is access, not hesitancy.

Activities that carry hepatitis B risk in special needs schools include:

• Intimate care, including toileting, continence support and catheterisation
• First aid for cuts, scrapes and bleeding wounds, which 94–98% of school staff perform at some point
• Managing behaviour that includes biting, scratching or spitting common in learners with profound and multiple learning difficulties
• Feeding support, including PEG feeding and oral hygiene
• Therapy interventions involving close physical contact

Yes. Under the Control of Substances Hazardous to Health Regulations 2002 (COSHH), every employer must assess the risk of exposure to biological agents, including hepatitis B virus and, where the risk is significant, provide vaccination at no cost to the employee. The British Medical Association’s published guidance is clear: occupational hepatitis B is the employer’s financial responsibility, and NHS GP practices cannot charge a registered patient for occupational hepatitis B vaccination.

For special needs schools, academies and multi-academy trusts, this means the school or trust commissions and pays for the programme on behalf of its staff. Staff bear no cost. Failing to provide vaccination where a meaningful risk has been identified exposes the school to potential HSE enforcement action and to civil liability if a member of staff later contracts hepatitis B at work.

The same duty applies to teaching assistants, learning support assistants, behavioural support staff, school nurses, physiotherapists, occupational therapists, midday supervisors, transport escorts, cleaning staff who handle clinical waste, and anyone else with regular intimate-care or first-aid responsibilities. The duty applies whether the school is maintained, an academy, an independent provider or a specialist independent school.

We offer all three Green Book-compliant hepatitis B vaccination schedules. The right choice depends on how quickly protection is needed and on how easily staff can be released from teaching duties. The accelerated schedule and very rapid schedule are particularly useful for new starters who need protection before they begin regular intimate-care duties.

Around 4 to 8 weeks after the third dose, we offer a confirmatory anti-HBs antibody blood test, with results recorded against each staff member. A titre of ≥10 mIU/mL confirms a protective response.

Non-responders, around 5 to 15% of healthy adults, more common in smokers, those with a BMI above 30, and people aged over 40, are offered a repeat course or further investigation in line with Green Book guidance.

Without an antibody titre check, the school cannot demonstrate that the vaccination programme has actually conferred protection, which is the whole point of running it.

Current UK guidance does not routinely recommend booster doses for healthy adults who have had a documented anti-HBs response above 10 mIU/mL. We document this clearly on each staff member’s record so that schools have an audit-ready position when the question is raised by occupational health auditors or inspectors.

Every staff member receives a personal vaccination record card and a digital certificate. The school receives a coded staff register showing course completion and antibody confirmation status, formatted for occupational health audit. Records are retained securely in line with GDPR, CQC and HSE requirements. Reports can be issued directly to the school’s occupational health provider on request.

All prices are per staff member. The school or trust is invoiced directly; staff pay nothing. Discounts apply for cohorts above 20 staff and for multi-school trusts commissioning across more than one site. Most schools opt for the full 3-dose course plus antibody titre check, invoiced as a single per-head price. We are happy to provide a fully costed proposal once we know the approximate staff numbers and preferred delivery model.

Yes. Under the COSHH Regulations 2002, employers must assess the risk of exposure to biological agents, including hepatitis B virus and provide vaccination at no cost to the employee where significant occupational risk is identified. The BMA confirms that NHS GP practices cannot charge patients for occupational hepatitis B vaccination the responsibility sits with the employer. For special needs schools, this means the school or MAT commissions and funds the programme.

A full course is three doses. The standard schedule runs at 0, 1 and 6 months. The accelerated schedule runs at 0, 1 and 2 months with a booster at 12 months. The very rapid schedule runs at 0, 7 and 21 days with a booster at 12 months. All three are Green Book-compliant. After the course, an anti-HBs antibody blood test confirms protective response (target ≥10 mIU/mL).

No. A single dose does not provide reliable protection against hepatitis B. The full three-dose course is required for the vast majority of people to mount a protective antibody response. Even after dose two, around 75% of healthy adults have a partial response but the third dose is what consolidates lifelong protection in most people. For school staff in occupational risk roles, partial vaccination should not be relied on, and the full course plus titre check is the only audit-defensible position.

For healthy adults who have demonstrated a protective antibody response (≥10 mIU/mL) after a full course, current UK guidance is that long-term protection is likely lifelong and routine boosters are not required. For at-risk staff in special needs schools who have responded to the vaccine, we document the titre clearly so that the school has an audit-ready position. People with weakened immune systems or those who failed to respond initially are managed individually.

No. The hepatitis B vaccine is not a live vaccine. It is a recombinant vaccine made using a piece of the hepatitis B surface antigen (HBsAg) produced by yeast cells. It contains no live virus, no whole virus and no infectious material. It cannot cause hepatitis B infection. This makes it safe for use in pregnant staff, breastfeeding staff and staff with most chronic health conditions, although individual screening always applies.

Yes. Hepatitis B vaccine is not a live vaccine and is considered safe in pregnancy. The Green Book confirms that pregnancy is not a contraindication to hepatitis B vaccination where there is a clear occupational or other risk. For pregnant school staff working in a special needs setting where the COSHH risk assessment has identified hepatitis B risk, vaccination should proceed rather than be deferred until after delivery. Individual screening is part of every consultation we run.

The vaccine protects against infection with the hepatitis B virus (HBV), which causes acute and chronic liver disease. Acute hepatitis B can cause jaundice, severe fatigue and rarely fulminant liver failure. Around 5% of adults who acquire hepatitis B develop chronic infection, which carries a long-term risk of cirrhosis and hepatocellular carcinoma (liver cancer). The vaccine does not protect against hepatitis A, hepatitis C, hepatitis D or hepatitis E though the combined Twinrix Adult vaccine covers both hepatitis A and B in a single course.

Around 5 to 15% of healthy adults do not produce a protective antibody response after the first course. Non-response is more common in smokers, in people with BMI above 30, and in those over 40. In line with the Green Book, we offer a repeat course of three doses, with a further antibody check afterwards. Persistent non-responders are documented as such and individual occupational risk management is discussed with the school.

Side effects are usually mild and short-lived. The most common are soreness, redness or mild swelling at the injection site for 24 to 48 hours. A small proportion of people experience a low-grade fever, mild headache, fatigue or muscle ache in the day or two after vaccination. These reactions reflect the immune system responding to the vaccine and resolve without treatment. Serious allergic reactions are very rare. Every dose we administer is preceded by a structured contraindication screening, and our clinical team is anaphylaxis-trained with full emergency equipment on site.

Protection starts to develop after the first dose, but full immunity usually requires completion of the full course. Standard schedules take around 6 months, while accelerated and very rapid schedules can provide earlier protection within weeks. For staff in special needs schools, faster schedules are often used where there is ongoing occupational exposure risk.